Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05504889 · ClinicalTrials.gov registry record
Cholesterol and CYP3A4/5 Metabolism Across Pregnancy and Postpartum
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 36
- Enrollment target
NCT05504889: Completed study, sponsored by Northwestern University.
NCT05504889 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05504889 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
This study addresses the second aim of the grant (R01 HD0899455), which is to determine temporal changes in CYP3A4-mediated drug metabolism sequentially across pregnancy and after birth.
Primary Outcome
plasma concentrations
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2022-06-17 |
| Est. Completion | 2023-06-30 |
What the finished NCT05504889 record still lists
NCT05504889 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05504889 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05504889 about?
NCT05504889 is a clinical study titled "Cholesterol and CYP3A4/5 Metabolism Across Pregnancy and Postpartum". This study addresses the second aim of the grant (R01 HD0899455), which is to determine temporal changes in CYP3A4-mediated drug metabolism sequentially across pregnancy and after birth.
What is the current status of trial NCT05504889?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2022-06-17. Estimated completion is 2023-06-30.
Who is sponsoring clinical trial NCT05504889?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI